Pomerantz LLP Investigates Encompass Health Securities Fraud Claims
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy EHC?
Source: PRnewswire
- Securities Fraud Investigation: Pomerantz LLP is investigating on behalf of investors of Encompass Health Corporation whether there have been securities fraud or other unlawful business practices, indicating serious concerns regarding corporate governance.
- Safety Issues Exposed: An article by The New York Times reported that for-profit hospitals operated by Encompass perform below average on key safety measures, particularly highlighting 34 facilities with statistically significantly worse rates of preventable readmissions, which may lead to decreased investor confidence.
- Significant Stock Drop: Following the publication of the report, Encompass's stock price fell by $12.39, or 10.35%, closing at $107.28 per share on July 15, 2025, reflecting market concerns over the quality of the company's operations.
- Potential Legal Consequences: Pomerantz LLP, recognized as a leading securities litigation firm, may initiate a class action lawsuit against Encompass if the investigation confirms wrongdoing, which could have significant implications for the company's future financial health and reputation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EHC
Wall Street analysts forecast EHC stock price to rise
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 100.630
Low
134.00
Averages
146.75
High
160.00
Current: 100.630
Low
134.00
Averages
146.75
High
160.00
About EHC
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Encompass Health Corp Secures $1 Billion Revolving Credit Facility with $260 Million Letter of Credit Subfacility in 2026 Credit Agreement - SEC Filing
Credit Agreement Overview: Compass Health Corp has secured a $1 billion revolving credit facility to enhance its financial flexibility.
Additional Credit Facility: The agreement includes a $260 million letter of credit sub-facility, providing further support for operational needs.
See More
Pomerantz LLP Investigates Encompass Health Securities Fraud Claims
- Securities Fraud Investigation: Pomerantz LLP is investigating on behalf of investors of Encompass Health Corporation whether there have been securities fraud or other unlawful business practices, indicating serious concerns regarding corporate governance.
- Safety Issues Exposed: An article by The New York Times reported that for-profit hospitals operated by Encompass perform below average on key safety measures, particularly highlighting 34 facilities with statistically significantly worse rates of preventable readmissions, which may lead to decreased investor confidence.
- Significant Stock Drop: Following the publication of the report, Encompass's stock price fell by $12.39, or 10.35%, closing at $107.28 per share on July 15, 2025, reflecting market concerns over the quality of the company's operations.
- Potential Legal Consequences: Pomerantz LLP, recognized as a leading securities litigation firm, may initiate a class action lawsuit against Encompass if the investigation confirms wrongdoing, which could have significant implications for the company's future financial health and reputation.
See More
U.S. Markets Closed Wednesday with Mixed Results as Nebius Group Outperformed and Fair Isaac Underperformed
Stock Market Performance: U.S. stock indexes ended Wednesday with mixed results, with one index increasing by 0.08%.
Index Movements: Another index also rose by 0.08%, while a third index experienced a decline of 0.61%.
See More
ENCOMPASS HEALTH CORP - DISCONTINUES 2022 CREDIT AGREEMENT AND SETTLES OUTSTANDING BALANCES - SEC FILING
Credit Agreement Termination: Compass Health Corp has terminated its 2022 credit agreement, signaling a significant financial decision.
Outstanding Amounts Paid Off: The company has successfully paid off outstanding amounts, indicating improved financial stability.
See More
Encompass Health Opens New Rehabilitation Hospital in South Carolina
- New Hospital Opening: Encompass Health has opened a 49-bed rehabilitation hospital in Irmo, South Carolina, now accepting patients and aiming to provide essential rehabilitation services for stroke, brain injury, and other patients to enhance their quality of life.
- Therapeutic Services: The hospital offers a minimum of 15 hours of intensive physical, occupational, and speech therapy weekly, combined with frequent physician visits and 24-hour nursing care, ensuring comprehensive support for patients during their recovery process to accelerate healing.
- Facility Design: The hospital features 49 private patient rooms, a spacious therapy gym, and activities of daily living simulation spaces equipped with advanced rehabilitation technologies, designed to meet diverse patient needs and improve recovery outcomes.
- Regional Impact: This marks Encompass Health's 11th location in South Carolina, highlighting the company's ongoing expansion in the region, which is expected to provide more accessible rehabilitation services to the local community and enhance the company's market competitiveness.
See More
Encompass Health to Participate in Barclays Global Healthcare Conference
- Conference Participation: Encompass Health will participate in the Barclays Global Healthcare Conference from March 10-12, 2026, with President and CEO Mark Tarr and CFO Doug Coltharp scheduled for a 25-minute fireside chat on March 11, which is expected to attract investor attention and enhance the company's visibility in the healthcare sector.
- Live Broadcast: The fireside chat will be broadcast live on Encompass Health's investor website, ensuring that a wide range of investors can access the latest company updates in real-time, thereby enhancing transparency and fostering investor engagement.
- Company Background: Encompass Health is the largest operator of inpatient rehabilitation hospitals in the U.S., with 173 hospitals across 39 states and Puerto Rico, dedicated to providing high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments to maximize recovery outcomes.
- Industry Recognition: The company is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista, and is ranked among Fortune's World's Most Admired Companies and Forbes' America's Best Companies, demonstrating its strong competitive position and excellent reputation in the industry.
See More
Encompass Health Corp Secures $1 Billion Revolving Credit Facility with $260 Million Letter of Credit Subfacility in 2026 Credit Agreement - SEC Filing
Credit Agreement Overview: Compass Health Corp has secured a $1 billion revolving credit facility to enhance its financial flexibility.
Additional Credit Facility: The agreement includes a $260 million letter of credit sub-facility, providing further support for operational needs.
See More
Pomerantz LLP Investigates Encompass Health Securities Fraud Claims
- Securities Fraud Investigation: Pomerantz LLP is investigating on behalf of investors of Encompass Health Corporation whether there have been securities fraud or other unlawful business practices, indicating serious concerns regarding corporate governance.
- Safety Issues Exposed: An article by The New York Times reported that for-profit hospitals operated by Encompass perform below average on key safety measures, particularly highlighting 34 facilities with statistically significantly worse rates of preventable readmissions, which may lead to decreased investor confidence.
- Significant Stock Drop: Following the publication of the report, Encompass's stock price fell by $12.39, or 10.35%, closing at $107.28 per share on July 15, 2025, reflecting market concerns over the quality of the company's operations.
- Potential Legal Consequences: Pomerantz LLP, recognized as a leading securities litigation firm, may initiate a class action lawsuit against Encompass if the investigation confirms wrongdoing, which could have significant implications for the company's future financial health and reputation.
See More
U.S. Markets Closed Wednesday with Mixed Results as Nebius Group Outperformed and Fair Isaac Underperformed
Stock Market Performance: U.S. stock indexes ended Wednesday with mixed results, with one index increasing by 0.08%.
Index Movements: Another index also rose by 0.08%, while a third index experienced a decline of 0.61%.
See More
ENCOMPASS HEALTH CORP - DISCONTINUES 2022 CREDIT AGREEMENT AND SETTLES OUTSTANDING BALANCES - SEC FILING
Credit Agreement Termination: Compass Health Corp has terminated its 2022 credit agreement, signaling a significant financial decision.
Outstanding Amounts Paid Off: The company has successfully paid off outstanding amounts, indicating improved financial stability.
See More
Encompass Health Opens New Rehabilitation Hospital in South Carolina
- New Hospital Opening: Encompass Health has opened a 49-bed rehabilitation hospital in Irmo, South Carolina, now accepting patients and aiming to provide essential rehabilitation services for stroke, brain injury, and other patients to enhance their quality of life.
- Therapeutic Services: The hospital offers a minimum of 15 hours of intensive physical, occupational, and speech therapy weekly, combined with frequent physician visits and 24-hour nursing care, ensuring comprehensive support for patients during their recovery process to accelerate healing.
- Facility Design: The hospital features 49 private patient rooms, a spacious therapy gym, and activities of daily living simulation spaces equipped with advanced rehabilitation technologies, designed to meet diverse patient needs and improve recovery outcomes.
- Regional Impact: This marks Encompass Health's 11th location in South Carolina, highlighting the company's ongoing expansion in the region, which is expected to provide more accessible rehabilitation services to the local community and enhance the company's market competitiveness.
See More
Encompass Health to Participate in Barclays Global Healthcare Conference
- Conference Participation: Encompass Health will participate in the Barclays Global Healthcare Conference from March 10-12, 2026, with President and CEO Mark Tarr and CFO Doug Coltharp scheduled for a 25-minute fireside chat on March 11, which is expected to attract investor attention and enhance the company's visibility in the healthcare sector.
- Live Broadcast: The fireside chat will be broadcast live on Encompass Health's investor website, ensuring that a wide range of investors can access the latest company updates in real-time, thereby enhancing transparency and fostering investor engagement.
- Company Background: Encompass Health is the largest operator of inpatient rehabilitation hospitals in the U.S., with 173 hospitals across 39 states and Puerto Rico, dedicated to providing high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments to maximize recovery outcomes.
- Industry Recognition: The company is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista, and is ranked among Fortune's World's Most Admired Companies and Forbes' America's Best Companies, demonstrating its strong competitive position and excellent reputation in the industry.
See More
